Pfizer to Pay $55M in Drug Misbranding Case

Published December 15, 2012

Pfizer to pay M in drug misbranding case

Filed under: drug treatment news 2012

Wyeth obtained FDA approval to promote Protonix only for short-term treatment of erosive esophagitis. The condition is associated with gastro-esophageal reflux disease. Wyeth allegedly promoted Protonix for all forms of GERD from February 2000 to June …
Read more on USA TODAY

'HIV is not transmitted by witchcraft ' | Health News 2012-12-15

Filed under: drug treatment news 2012

The celebration, on the theme: “Getting to Zero: Zero New Infections, Zero Discrimination, Zero AIDS Related Deaths' – Accelerating to Zero Together”, also aimed at encouraging the utilisation of HIV testing and treatment services and for the public to …
Read more on GhanaWeb

Winding Down 2012 With Last-Minute Bets On Alexza

Filed under: drug treatment news 2012

Alexza's case for ADASUVE specifically lies in the notion that rapid delivery of loxapine to the brain is crucial for the treatment of agitation symptoms in schizophrenia. This eliminates oral tablets due to their slow absorption … It's hard to say …
Read more on Seeking Alpha